Showing results (61-70 of 102) with videos related to
Sort By:
Pageof 11
Breast Cancer Research and Treatment|February 8, 2020
Management of brain metastases in breast cancer: a review of current practices and emerging treatmentsMatthew N Mills, Nicholas B Figura, John A Arrington, et al.Breast Cancer Research and Treatment|February 3, 2018
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experienceNicholas B Figura, Wendy Long, Michael Yu, et al.Cancer Causes & Control : CCC|March 6, 2017
Older age at the completion of linear growth is associated with an increased risk of adult gliomaRebecca B Little, L Burt Nabors, Jeffrey J Olson, et al.Cell Reports. Medicine|June 12, 2024
Spatial transcriptomics analysis identifies a tumor-promoting function of the meningeal stroma in melanoma leptomeningeal diseaseHasan Alhaddad, Oscar E Ospina, Mariam Lotfy Khaled, et al.Cancer|October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN productionTommy Alain, XueQing Lun, Yvan Martineau, et al.Cancer Research|June 18, 2003
Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastomaWen Qing Yang, Donna Senger, Huong Muzik, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 17, 2009
Population-based study of pseudoprogression after chemoradiotherapy in GBMGloria B Roldán, James N Scott, John B McIntyre, et al.Journal of Neuro-Oncology|February 3, 2024
Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgeryJoseph D Tang, Matthew N Mills, Justyn Nakashima, et al.The Journal of Biological Chemistry|February 13, 2014
p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cellsPeter A Forsyth, Niveditha Krishna, Samuel Lawn, et al.Pageof 11